Clinical trials
Postoperative Nausea and Vomiting trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 9 |
| 2023 | 7 |
| 2024 | 9 |
| 2025 | 6 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Unknown status | 14 |
| Recruiting | 8 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University First Hospital | 4 |
| Sixth Affiliated Hospital, Sun Yat-sen University | 4 |
| The Second Affiliated Hospital of Chongqing Medical University | 4 |
| Weifang Medical University | 4 |
| Beijing Tiantan Hospital | 3 |
| Peking Union Medical College Hospital | 3 |
| Shanghai Zhongshan Hospital | 2 |
| The Second Hospital of Anhui Medical University | 2 |
| Affiliated Hospital of Nantong University | 1 |
| Anqing Municipal Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Postoperative Nausea and Vomiting | 54 |
| Postoperative Complications | 2 |
| Breast Neoplasms | 1 |
| Cholelithiasis | 1 |
| Dizziness | 1 |
| Emergence Delirium | 1 |
| Gallstones | 1 |
| Insulin Resistance | 1 |
| Leiomyoma | 1 |
| Motion Sickness | 1 |
Trials
Showing 51 to 54 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.